A recent Forbes article on the resurrection of the gene therapy business featured The Children’s Hospital of Philadelphia gene therapy expert Katherine A. High, MD.
Category Archive: Genetics
Apr 14 2014
Permanent link to this article: http://www.research.chop.edu/blog/forbes-article-features-chop-gene-therapy-expert/
Apr 11 2014
Permanent link to this article: http://www.research.chop.edu/blog/new-ipad-app-helps-construct-genetic-pedigrees/
Dec 11 2013
For her pioneering hemophilia and gene therapy research, Children’s Hospital hematologist Katherine A. High, MD, director of the Center for Cellular and Molecular Therapeutics (CCMT), was recently honored with the 2013 E. Donnall Thomas Lecture and Prize at the American Society of Hematology (ASH) Annual Meeting.
Permanent link to this article: http://www.research.chop.edu/blog/chop-hematologist-gene-therapy-researcher-honored/
Apr 16 2013
Permanent link to this article: http://www.research.chop.edu/blog/marketplace-report-on-dna-sequencing-features-chop-doc/
Apr 08 2013
Permanent link to this article: http://www.research.chop.edu/blog/cast-your-vote-for-ian-krantz-and-nancy-spinner-for-the-time-100/
Feb 19 2013
Permanent link to this article: http://www.research.chop.edu/blog/chop-study-finds-link-between-genes-and-lifespan/
Feb 07 2013
The idea of “personalized” medicine isn’t just about a one-on-one encounter with a doctor, the use of sophisticated mobile applications, or heightened access to healthcare providers, medical records, and services. Personalized medicine also extends into the depths of who each of us are at our essence — to our individual genetic makeup.
Permanent link to this article: http://www.research.chop.edu/blog/the-cornerstone-of-personalized-medicine/
Jan 28 2013
Permanent link to this article: http://www.research.chop.edu/blog/religion-and-ethics-newsweekly-on-genetic-testing/
Jan 25 2013
Permanent link to this article: http://www.research.chop.edu/blog/chop-geneticists-to-be-featured-on-religion-ethics-newsweekly/
Jan 24 2013
A recent genomic study of neuroblastoma reinforces the challenges of treating the most aggressive forms of this disease. Contrary to expectations, the researchers found relatively few recurrent gene mutations — mutations that would suggest new targets for neuroblastoma treatment. Instead, the investigators have refocused on how neuroblastoma tumors evolve in response to medicine and other factors.
Permanent link to this article: http://www.research.chop.edu/blog/study-shows-neuroblastoma-evolves-rapidly-limiting-treatment-targets/